DADC
BSX icon

D.A. Davidson & Co’s Boston Scientific BSX Stock Holding History

D.A. Davidson & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$941K Sell
14,998
-289
-2% -$23.1K 0.01% 952
2025
Q4 		$1.46M Buy
15,287
+27
+0.2% +$2.65K 0.01% 772
2025
Q3 		$1.49M Buy
15,260
+2,628
+21% +$272K 0.01% 743
2025
Q2 		$1.36M Buy
12,632
+1,096
+10% +$111K 0.01% 726
2025
Q1 		$1.16M Buy
11,536
+504
+5% +$50.8K 0.01% 721
2024
Q4 		$985K Buy
11,032
+87
+0.8% +$7.66K 0.01% 774
2024
Q3 		$917K Buy
10,945
+342
+3% +$27K 0.01% 788
2024
Q2 		$817K Buy
10,603
+184
+2% +$13.5K 0.01% 798
2024
Q1 		$714K Buy
10,419
+1,039
+11% +$66.8K 0.01% 852
2023
Q4 		$542K Buy
9,380
+529
+6% +$28.2K 0.01% 918
2023
Q3 		$467K Buy
8,851
+311
+4% +$16.3K 0.01% 931
2023
Q2 		$462K Buy
8,540
+111
+1% +$5.8K ﹤0.01% 947
2023
Q1 		$422K Sell
8,429
-1,400
-14% -$66K ﹤0.01% 941
2022
Q4 		$455K Sell
9,829
-371
-4% -$16.1K 0.01% 877
2022
Q3 		$395K Buy
10,200
+171
+2% +$6.86K 0.01% 895
2022
Q2 		$374K Buy
10,029
+1,665
+20% +$67.8K ﹤0.01% 925
2022
Q1 		$370K Buy
8,364
+60
+0.7% +$2.6K ﹤0.01% 997
2021
Q4 		$353K Buy
8,304
+153
+2% +$6.43K ﹤0.01% 1000
2021
Q3 		$354K Hold
8,151
– – ﹤0.01% 945
2021
Q2 		$349K Sell
8,151
-240
-3% -$10.1K ﹤0.01% 935
2021
Q1 		$324K Buy
8,391
+550
+7% +$20.8K ﹤0.01% 934
2020
Q4 		$282K Sell
7,841
-34,360
-81% -$1.24M ﹤0.01% 870
2020
Q3 		$1.61M Buy
42,201
+14,017
+50% +$540K 0.03% 349
2020
Q2 		$990K Buy
28,184
+6,155
+28% +$222K 0.02% 444
2020
Q1 		$719K Buy
22,029
+2,148
+11% +$83.9K 0.01% 518
2019
Q4 		$899K Buy
19,881
+437
+2% +$18.3K 0.01% 529
2019
Q3 		$791K Sell
19,444
-1,348
-6% -$57.1K 0.01% 538
2019
Q2 		$894K Sell
20,792
-1,999
-9% -$76.9K 0.02% 500
2019
Q1 		$823K Sell
22,791
-204
-0.9% -$7.79K 0.01% 554
2018
Q4 		$813K Sell
22,995
-2,127
-8% -$77.1K 0.02% 521
2018
Q3 		$967K Buy
25,122
+1,325
+6% +$46.3K 0.02% 518
2018
Q2 		$778K Buy
23,797
+458
+2% +$13.8K 0.02% 576
2018
Q1 		$638K Sell
23,339
-7,141
-23% -$194K 0.01% 606
2017
Q4 		$756K Sell
30,480
-2,624
-8% -$72.4K 0.02% 536
2017
Q3 		$965K Sell
33,104
-29
-0.1% -$801 0.02% 513
2017
Q2 		$918K Buy
33,133
+3,814
+13% +$101K 0.02% 473
2017
Q1 		$729K Sell
29,319
-3,298
-10% -$80.2K 0.02% 513
2016
Q4 		$705K Buy
32,617
+513
+2% +$11.2K 0.02% 562
2016
Q3 		$763K Buy
32,104
+25,694
+401% +$613K 0.02% 524
2016
Q2 		$149K Sell
6,410
-4,067
-39% -$88K ﹤0.01% 950
2016
Q1 		$196K Buy
10,477
+629
+6% +$11K 0.01% 842
2015
Q4 		$180K Buy
9,848
+22
+0.2% +$394 0.01% 875
2015
Q3 		$160K Buy
9,826
+474
+5% +$8.1K 0.01% 904
2015
Q2 		$163K Buy
9,352
+2,200
+31% +$39.3K 0.01% 944
2015
Q1 		$125K Buy
7,152
+5,157
+258% +$81.5K ﹤0.01% 1036
2014
Q4 		$26K Sell
1,995
-2,457
-55% -$31.4K ﹤0.01% 1609
2014
Q3 		$51K Sell
4,452
-1,000
-18% -$12.6K ﹤0.01% 1398
2014
Q2 		$68K Sell
5,452
-1,531
-22% -$19.9K ﹤0.01% 1297
2014
Q1 		$92K Sell
6,983
-2,460
-26% -$32.3K ﹤0.01% 1179
2013
Q4 		$113K Sell
9,443
-2,811
-23% -$33.2K ﹤0.01% 1013
2013
Q3 		$143K Sell
12,254
-1,145
-9% -$12.4K 0.01% 792
2013
Q2 		$123K Buy
+13,399
New +$114K 0.01% 806

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

D.A. Davidson & Co's BSX Position: Q1 2026 in Review

D.A. Davidson & Co reduced its Boston Scientific (BSX) stake by 1.9% in Q1 2026, selling an estimated $23.1K and leaving 14,998 shares worth $941K. The position accounts for 0.01% of the portfolio, ranked #952.

D.A. Davidson & Co first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.61M in Q3 2020. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • D.A. Davidson & Co held 14,998 shares of Boston Scientific worth $941K as of Q1 2026.
  • D.A. Davidson & Co sold 289 Boston Scientific shares in Q1 2026, an estimated $23.1K.
  • Boston Scientific made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #952 holding.
  • D.A. Davidson & Co first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • D.A. Davidson & Co's Boston Scientific position peaked at $1.61M in Q3 2020.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.